Search results

Found 5,198 pages
AUTHOR: Kevin Grogan

Your search yielded no results

  • Check if your spelling is correct.
  • Remove quotes around phrases to search for each word individually. bike shed will often show more results than "bike shed".
  • Consider loosening your query with OR. bike OR shed will often show more results than bike shed.

B-MS inks fibrosis pact with Calibr

Bristol-Myers Squibb has linked up with the California Institute for Biomedical Research to develop anti-fibrotic therapies. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/b-ms_inks_fibrosis_pact_with_calibr_970805

Recordati acquires Tunisia's Opalia

Recordati is buying a 90% stake in Opalia Pharma of Tunisia in a deal valued at 80 million dinar, or around 37 million euros. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/recordati_acquires_tunisias_opalia_1005440

Shire extends offer for ViroPharma again

Shire has extended its tender offer to buy ViroPharma for a second time, now expiring on midnight January 23. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/shire_extends_offer_for_viropharma_again_1001342

Roche signs Parkinson's pact with 23andMe

Roche’s Genentech unit has linked up with personal genetics company 23andMe to identify new therapeutic targets for Parkinson’s disease. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/roche_signs_parkinsons_pact_with_23andme_970837

Nestle pact with stem cell biotech CDI

Food giant Nestle has linked up with USA-based stem cell specialist Cellular Dynamics International. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/nestle_pact_with_stem_cell_biotech_cdi_1001327

Shire launches bid to buy Movetis

Shire has launched its 19 euros per share offer for Belgium's Movetis. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/shire_launches_bid_to_buy_movetis_982484

Europe approves J&J diabetes combo Vokanamet

Regulators in Europe have given the green light to Johnson & Johnson's new diabetes therapy Vokanamet. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/europe_approves_j_and_j_diabetes_combo_vokanamet_1001869

XTL buys Teva's stake in Proteologics

XTL Biopharmaceuticals has bought a major stake in fellow Israeli drugmaker Proteologics from Teva Pharmaceutical Industries. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/xtl_buys_tevas_stake_in_proteologics_976154

Bayer streamlines healthcare ops

Bayer is putting in place measures which it claims will cut down on administration and promote innovation. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/bayer_streamlines_healthcare_ops_979675

Roche buys German genomics group Signature

Roche has hit the acquisition trail again to buy privately-held Signature Diagnostics of Germany. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/roche_buys_german_genomics_group_signature_971024

Latest jobs

View all

What job are you looking for?

This field is required.

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download